Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Retina Center, Minnesota
With
Genentech, Inc.
Age
55–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Ability to provide written informed consent and comply with study assessments for the full duration of the study
Age \>55 years
Patients to be included in the study must have AMD with choroidal neovascularization
BCVA between 20/20 - 20/400
Lesion size less than or equal to 12 MPS disc areas
You may not be if
Prior treatment with an anti-VEGF agent within 6 months of enrollment in this study
Pregnancy (positive pregnancy test)
Premenopausal women not using adequate contraception. The following are considered effective means of contraception: surgical sterilization or use of oral contraceptives, barrier contraception with either a condom or diaphragm in conjunction with spermicidal gel, an IUD, or contraceptive hormone implant or patch
Prior enrollment in the study
Any other condition that the investigator believes would pose a significant hazard to the subject if the investigational therapy were initiated
Participation in another simultaneous medical investigation or trial